Found: 5
Select item for more details and to access through your institution.
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 1, p. 41, doi. 10.1111/j.1365-2036.2007.03347.x
- By:
- Publication type:
- Article
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring– a randomized trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 2, p. 155, doi. 10.1111/j.1365-2036.2005.02313.x
- By:
- Publication type:
- Article
Non-erosive reflux disease (NERD) — acid reflux and symptom patterns.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 4, p. 537, doi. 10.1046/j.1365-2036.2003.01423.x
- By:
- Publication type:
- Article
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy—a prospective, randomized, multi-centre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2000, v. 14, n. 12, p. 1595, doi. 10.1046/j.1365-2036.2000.00882.x
- By:
- Publication type:
- Article
Assessment of 24-h oesophageal pH monitoring should be divided to awake and asleep rather than upright and supine time periods.
- Published in:
- Neurogastroenterology & Motility, 2007, v. 19, n. 9, p. 709, doi. 10.1111/j.1365-2982.2007.00929.x
- By:
- Publication type:
- Article